Studieenheten Akademiskt Specialistcentrum

Verifiedinfo

Sweden Olivecronas väg 15, 113 61 Stockholm, Sweden

1 trial recruiting
Respiratory syncytial virus infection · Lyme disease
Adults and children

About Specializations

Studieenheten Akademiskt Specialistcentrum in Stockholm, Sweden specialises in clinical trials of conditions such as Respiratory syncytial virus infection, Lyme disease, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases at Studieenheten Akademiskt Specialistcentrum

This neurology research site in Stockholm is focused on Nervous System Diseases, with clinical studies centered on Amyotrophic Lateral Sclerosis. The trials are aimed at advancing understanding of this serious neurodegenerative condition and evaluating new treatment options for people affected by it.

Research into Amyotrophic Lateral Sclerosis and related neurology care
Studies exploring new therapies for sporadic and familial ALS

The clinical research at Studieenheten Akademiskt Specialistcentrum is helping assess whether emerging approaches may improve disease management and support future treatment development.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Olivecronas väg 15113 61 StockholmSweden

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 2
Partner status: Verified

More sites in Stockholm Sweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Respiratory syncytial virus infection

Recruiting

Registered drugNo placebo

Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:Karolinska Institutet

Contact Research Centre

Lyme disease

Not recruiting

Registered drug

Study on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older

Registered drug

Sweden

Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
Substances:Sodium Chloride Solution 0.9%
Sponsor:Pfizer Inc.

Contact Research Centre

Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites